Plenary One: Opioids

Session Chair: Ms Carolyn Paterson

Using linked cohorts to examine population-wide effects of opioid agonist treatments in NSW. | Scientia Professor Louisa Degenhardt, AO

Keynote Address: The UK supervised heroin treatment trial: success and failure to advance science, policy and practice. | Professor Sir John Strang

Keynote Address: Examining Trends in Drug-Related Deaths – the crucial importance of cohorts in informing our understanding of changing risks and harms. | Professor Matthew Hickman

Global coverage of interventions to prevent and manage injecting drug use related harms in prisons: a systematic review. | Dr Thomas Santo Jr

Development of opioid use disorder following treatment with opioid analgesics for non-cancer pain relief: an Australian state-wide nested case-control study. | Dr Chrianna Bharat

Poster Presentations

Session Chair: Professor Mel Miller

Ms Joanna Zhou: Retention in opioid agonist treatment following childbirth and associated factors.

Ms Kendal Chidwick: Trends in prescription opioid analgesic utilisation in Australia from 2015 to 2022.

Dr Ria Hopkins: Age, period, and cohort trends of substance poisoning, alcohol-related disease, and suicide deaths in Australia, 1980-2019..

Ms Olivia Price: Population ageing and the apparent decline in the initiation of injecting drug use in Australia.

Dr Tayla Degan: Co-occurring DSM-IV mental disorders among people with methamphetamine dependence.

Ms Emily Symes: Presentations and characteristics of trans and gender-diverse patients presenting to an Australian Emergency Department.

Plenary Two: New, Novel, and Trending

Session Chair: Professor Nadine Ezard

The Changing Face of Overdose. | Professor Shane Darke

Emerging drugs of concern - Prompt Response Network update.| Dr Brendan Clifford

Emerging drug use, harms, and markets trends: Findings from Drug Trends 2024. | Dr Rachel Sutherland

Breakout One: Treatment & Trials

Session Chair: Professor Apo Demirkol

New behavioural and pharmacological trials for smoking cessation. | Associate Professor Ryan Courtney & Professor Hayden McRobbie

LAIB in Prison: A report on qualitative data from patients who commenced treatment during a clinical trial. | Dr Amelia Woods

The impact of the NSW MERIT diversion program reoffending, imprisonment, and health. | Professor Donald Weatherburn

We need to talk about contingency management. | Associate Professor Rebecca McKetin

Breakout Two: Community Engagement & Responses

Session Chair: Ms Lisa Russell

Defining approaches and research evidence around Community Action to reduce AOD harms | Dr Peter Gates

Due to a camera failure in 'Breakout Two: Community Engagement & Responses', not all recordings have been captured. These presentations are being rerecorded and will be available shortly.

Breakout Three: Strong Foundations: Pregnancy & Families

Session Chair: Dr Hester Wilson

Influences of methamphetamine use on family relationships: Interviews with family members. | Ms Paige Webb

Effectiveness of prescription smoking cessation pharmacotherapies during pregnancy: a multi-national study. | Dr Alys Havard

Trends in the use of opioid agonist treatment for opioid dependence in pregnancy. | Dr Duong Tran

Use of opioid agonist therapy in pregnancy: Timing of initiation and treatment retention. | Ms Bianca Varney

Plenary Three: Alcohol

Session Chair: Mr Matthew Craig

WHO's Global Alcohol Action Plan 2022–2030.  What are the critical issues for Prevention and Policy? | Professor Jürgen Rehm

Recent trends in alcohol use and harms in Australia. | Dr Wing See Yuen

Alcohol Retailers Lobbying activities: A Comparative Analysis of profit and Non-profit alcohol retail industry body policy submissions. | Dr Michala Kowalski